Friday, April 11, 2008

Lawsuit claims "CSI" toy kits contain asbestos

A California asbestos awareness group sued CBS Corp, a toy maker and several retailers on Friday, claiming they sold toy crime-scene kits based on the hit CBS series "CSI: Crime Scene Investigation" that contained the cancer-causing substance.

The lawsuit, filed in Los Angeles Superior Court, alleges that laboratory tests revealed the fingerprint dusting powder in the kits contained "substantial quantities of tremolite asbestos ... one of the most lethal forms of asbestos."

New York-based manufacturer Planet Toys Inc pulled the kits from the market late last year over the group's claims but said that multiple tests had shown no traces of asbestos.
The company said on its Web site it had issued a "stop sale" on all "CSI" fingerprint kits "until further information can be ascertained as to the discrepancy between our respective test findings."

The nonprofit Asbestos Disease Awareness Organization said the defendants, including Planet Toys, failed to warn consumers the kits contained a hazardous material, as required under state law.

The group seeks a court order to stop sales of the kits unless they carry the warning and to require the companies to allow purchasers to return the kits for a full refund, as well as civil penalties.

Friday, April 04, 2008

Myth: Asbestos a Thing of the Past

According to an article on deaths from mesothelioma/asbestos, each year, 10,000 Americans die -- often quite painfully - due to asbestos-related illnesses. Because it takes between 10 and 50 years for symptoms to emerge, these numbers are expected to climb through 2018.

"People think asbestos is a thing of the past," said Harbut, M.D., co-director of the National Center for Vermiculite and Asbestos-Related Cancers, at the Karmanos Cancer Institute in Detroit, adding that inhaling or swallowing asbestos fibers permanently penetrates the lungs and other tissue, causing cancer and other respiratory diseases. "I wish it were."

This weekend Harbut is increasing awareness regarding early detection at The Asbestos Disease Awareness Organization's fourth annual Asbestos Awareness Day Conference in Detroit.
His goal is to educate and provide outreach to those impacted by exposure. Scheduled events include a musical performance by Jordan Zevon, son of legendary rock musician Warren Zevon, who died of an asbestos-related illness in 2003.

At 10:30 a.m. today, participants will join people around the globe in celebrating the memory of those who died of related diseases with a candlelight ceremony and brunch at the Detroit Marriot Renaissance Center.

"There's a place you can go to find out if you are at high risk for developing asbestos cancers - and get some help," Harbut said. "Karmanos is generally thought to be at the forefront of asbestos research."

Harbut's research team is recognized for discovering two early tumor markers for asbestos-related disease, as revealed through a blood test.

"Early detection helps people live longer and less painfully -- and hopefully less tragically for the family," Harbut said. "It can take a very brief exposure to be affected. There's no such thing as a safe level of exposure."

Between 4,000 and 8,000 new cases of mesothelioma are discovered in the United States each year. Asbestos is the only known cause. According to Harbut, it's the smallest percentage of asbestos-related cancers. Tens of thousands of others are expected to die of lung cancer, asbestosis and other related illnesses.

Thursday, March 27, 2008

Mouse Model for Mesothelioma Reproduces Human Disease



According to an article on mesothelioma research, scientists have established a mouse model for human malignant mesothelioma that will provide valuable insight into cancer development and progression along with new directions for design of therapeutic strategies. The research, published by Cell Press in the March issue of Cancer Cell, may eventually lead to a substantially improved outlook for patients with this devastating disease.




Chemotherapy can sometimes lead to improvement of overall survival but there is no cure for malignant mesothelioma and patients often succumb from the disease within a year of diagnosis. "There is an urgent need for experimental models of malignant mesothelioma that can be used to not only study the onset and progression of the disease, but also to serve as a model to select new combination therapies and targeted agents," says study leader, Dr. Anton Berns, from The Netherlands Cancer Institute.



In humans, malignant mesothelioma has been associated with genetic lesions that result in the loss of Neurofibromatosis type 2 (NF2) and genetic lesions affecting RB and P53 pathways. Dr. Berns' team investigated whether a range of conditional single or compound mutations in the Nf2, p53 and Rb pathways within the mesothelial lining of the thoracic cavity would cause malignant mesothelioma in mice.



The researchers found that the vast majority of mice with conditional Nf2;Ink4a/Arf and Nf2;p53 mutations developed MM after a short latency period. The mouse malignant mesothelioma tumors, which could be followed noninvasively through the use of bioluminescence imaging, closely resembled human MM. Interestingly, Nf2;Ink4a/Arf knockout mice had a more invasive cancer when compared with Nf2;p53 knockout mice. The researchers went on to show that the loss of Ink4a makes a substantial contribution to the poor clinical outcome of murine malignant mesothelioma.



These results describe an excellent model system for investigating the molecular mechanisms that underlie malignant mesothelioma . "Our mouse models should be suitable to further dissect pathways critically important in mesothelioma development and progression and serve as invaluable tools to test new intervention strategies," concludes Dr. Berns. "We have also derived a series of cell lines that reproduce the disease when grafted into the thoracic cavity. These may also facilitate design of better MM therapies."

Thursday, March 20, 2008

Useful asbestos website

The Department of Health and Human Services has a useful website with a great deal of information regarding asbestos, including what it is, types of asbestos exposure, health effects, what you can do if you’re exposed to it, FAQs, info on lung cancer and mesothelioma, plus a variety of links to other valuable resources.

Thursday, March 13, 2008

W.R. Grace on verge of making legal history

According to an editorial on the Wall Street Journal’s website on asbestos and mesothelioma, W.R. Grace is on the verge of making legal history with a trial proceeding that could alter the federal asbestos bankruptcy landscape forever.

A building materials company, W.R. Grace was among the firms swept up in a second round of asbestos litigation in the late 1990s. Having chewed their way through asbestos manufacturers, trial lawyers went after companies that had only a marginal asbestos link. By blanketing these firms with an avalanche of claims they recruited, the tort bar pushed at least 30 of these second-tier players into bankruptcy.

The company entered Chapter 11 with some 120,000 pending claims. But Judge Fitzgerald allowed it to send a medical questionnaire to those plaintiffs, and to request proof of a claim. Some 35,000 didn't bother to finish that process.

The vast majority of asbestos claims are bogus. The plaintiffs lawyers know it, which is why, instead of trying to defend these claims, they've fought every attempt by Grace to examine them. Now that they've lost that battle, they argue that because Grace settled such claims in the past, they should continue to pay them going forward.


If Judge Fitzgerald does discount most of these claims, it could mark the beginning of the end of the bankruptcy racket. Other judges will find it difficult to ignore the evidence and procedures here. As important, trial lawyers might be reluctant to push more companies (in asbestos or other mass torts) into bankruptcy court if they think false claims may be exposed.


This clean-up would obviously come too late for the dozens of companies that have already surrendered to asbestos trusts now run by the tort bar. But it's encouraging that courts are finally investigating sham asbestos claims. It's never too late for real justice.

Friday, March 07, 2008

Mesothelioma Q & A

Here is a short version of a Q & A from the National Cancer Institute’s website, with some useful answers to questions readers may have about mesothelioma, asbestos and health-related risks...

Mesothelioma is a rare form of cancer in which malignant (cancerous) cells are found in the mesothelium, a protective sac that covers most of the body’s internal organs. Most people who develop mesothelioma have worked on jobs where they inhaled asbestos particles.

1. What is the mesothelium?
The mesothelium is a membrane that covers and protects most of the internal organs of the body. It is composed of two layers of cells: One layer immediately surrounds the organ; the other forms a sac around it. The mesothelium produces a lubricating fluid that is released between these layers, allowing moving organs (such as the beating heart and the expanding and contracting lungs) to glide easily against adjacent structures.

2. What is mesothelioma?
Mesothelioma (cancer of the mesothelium) is a disease in which cells of the mesothelium become abnormal and divide without control or order. They can invade and damage nearby tissues and organs. Cancer cells can also metastasize (spread) from their original site to other parts of the body.

3. How common is mesothelioma?
Although reported incidence rates have increased in the past 20 years, mesothelioma is still a relatively rare cancer. About 2,000 new cases of mesothelioma are diagnosed in the United States each year. Mesothelioma occurs more often in men than in women and risk increases with age, but this disease can appear in either men or women at any age.

4. What are the risk factors for mesothelioma?
Working with asbestos is the major risk factor for mesothelioma. A history of asbestos exposure at work is reported in about 70 percent to 80 percent of all cases. However, mesothelioma has been reported in some individuals without any known exposure to asbestos. Smoking does not appear to increase the risk of mesothelioma. However, the combination of smoking and asbestos exposure significantly increases a person’s risk of developing cancer of the air passageways in the lung.

5. Who is at increased risk for developing mesothelioma?
Initially, the risks associated with asbestos exposure were not known. However, an increased risk of developing mesothelioma was later found among shipyard workers, people who work in asbestos mines and mills, producers of asbestos products, workers in the heating and construction industries, and other tradespeople.

Today, the U.S. Occupational Safety and Health Administration (OSHA) sets limits for acceptable levels of asbestos exposure in the workplace. People who work with asbestos wear personal protective equipment to lower their risk of exposure. The risk of asbestos-related disease increases with heavier exposure to asbestos and longer exposure time. However, some individuals with only brief exposures have developed mesothelioma.

On the other hand, not all workers who are heavily exposed develop asbestos-related diseases. There is some evidence that family members and others living with asbestos workers have an increased risk of developing mesothelioma, and possibly other asbestos-related diseases.

6. What are the symptoms of mesothelioma?
Symptoms of mesothelioma may not appear until 30 to 50 years after exposure to asbestos. Shortness of breath and pain in the chest due to an accumulation of fluid in the pleura are often symptoms of pleural mesothelioma. Symptoms of peritoneal mesothelioma include weight loss and abdominal pain and swelling due to a buildup of fluid in the abdomen. Other symptoms of peritoneal mesothelioma may include bowel obstruction, blood clotting abnormalities, anemia, and fever.

If the cancer has spread beyond the mesothelium to other parts of the body, symptoms may include pain, trouble swallowing, or swelling of the neck or face. These symptoms may be caused by mesothelioma or by other, less serious conditions. It is important to see a doctor about any of these symptoms. Only a doctor can make a diagnosis.

7. How is mesothelioma diagnosed?
Diagnosing mesothelioma is often difficult, because the symptoms are similar to those of a number of other conditions. Diagnosis begins with a review of the patient’s medical history, including any history of asbestos exposure. A complete physical examination may be performed, including x-rays of the chest or abdomen and lung function tests. A CT (or CAT) scan or an MRI may also be useful. A biopsy is needed to confirm a diagnosis of mesothelioma.

8. How is mesothelioma treated?
Treatment for mesothelioma depends on the location of the cancer, the stage of the disease, and the patient’s age and general health. Standard treatment options include surgery, radiation therapy, and chemotherapy. Sometimes, these treatments are combined.

9. Are new treatments for mesothelioma being studied?
Yes. Because mesothelioma is very hard to control, the National Cancer Institute (NCI) is sponsoring clinical trials (research studies with people) that are designed to find new treatments and better ways to use current treatments. Before any new treatment can be recommended for general use, doctors conduct clinical trials to find out whether the treatment is safe for patients and effective against the disease. Participation in clinical trials is an important treatment option for many patients with mesothelioma.

---------
If you, a coworker or a family member has been exposed to asbestos, contact the law firm of LEVY PHILLIPS & KONIGSBERG, LLP. LPK has been a pioneer in representing victims of asbestos exposure, and is one of the nation’s premier law firms in the areas of toxic torts, product liability, personal injury, and discrimination law.

Thursday, February 21, 2008

Asbestos Exposure Slows Hurricane Katrina Cleanup

Cleanup from Hurricane Katrina continues to be slow because of possible asbestos exposure. In a New Orleans parish, officials have determined to use a controlled burn rather than to demolish and move debris to a landfill, which could increase the potential for asbestos contamination.


Because of the large number of asbestos-contaminated buildings and debris still sitting in a New Orleans parish from Hurricane Katrina, a controlled cleanup burn will occur. Three years after the hurricane hit New Orleans, officials are unable to demolish several buildings for fear that asbestos dust will contaminate surrounding areas. Instead, the U.S. Environmental Protection Agency (EPA) has proposed a controlled burn of the wreckage in a specially designed incinerator, which will occur while air quality is monitored.

Asbestos is a highly toxic mineral that was used in the construction of homes, schools, universities, government buildings and office buildings. The mineral was used because of its resistance to heat and fire damage as well as its strength, however, it was discovered that the inhalation of asbestos fibers and dust was highly toxic to individuals and can cause asbestosis and mesothelioma cancer.

It can take years and even decades for those affected by mesothelioma to know they have been afflicted with the incurable illness. Mesothelioma is not only often misdiagnosed but when it is not caught early enough, there is no possibility to postpone or cure the disease. Those who suspect they have been exposed to asbestos should contact a mesothelioma doctor to learn about treatments. Additionally, it is advisable to consult a mesothelioma attorney for information on how to file mesothelioma litigation.


In the New Orleans parish, officials have determined to burn three asbestos contaminated buildings by using an incinerator known as an "air curtain destructor." In addition to this the EPA will be monitoring the air quality of the burn to ensure that there is no toxic.

Similar to mesothelioma is a disease known as Nephrogenic Systemic Fibrosis (NSF), which is a rare skin disorder associated with patients of kidney disease who are receiving gadolinium dye during magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) tests. NSF causes a victim's skin to swell, thicken and eventually harden. The skin also forms swollen red scabs, which can be painful. Also, because of the skins hardening, specifically around the limb's joints, it may become difficult for a victim to function on their own.

Friday, February 15, 2008

Inspiring letter from cancer survivor

Here’s an excerpt from an inspiring letter, and valuable advice, from a Mesothelioma survivor. Read the entire letter here.


Dear Fellow Cancer Patient:


I'm Dick Bloch. In March, 1978 I was diagnosed with terminal lung cancer and given 3 months to live by an outstanding doctor. I am now healthy, cancer free, and devoting myself along with my wife, Annette, to helping the next person with cancer have the best chance of beating it. I'm not saying you can have the same success I did, but if you try, you have a chance.

The biggest and the hardest single thing that you will be required to do in the entire battle is to make up your mind to really fight it. You must, on your own, make the commitment that you will do everything in your power to fight your disease. No exceptions. Nothing halfway. Nothing for the sake of ease or convenience. Everything! Nothing short of it. When you have done this, you have accomplished the most difficult thing you will have to accomplish throughout your entire treatment. And I don't care how serious or how minor you are led to believe your cancer is.

Remember, once you have made the commitment, everything else is relatively easy. There will be pleasant experiences. There will be unpleasant experiences. But I can promise you it is not as difficult as making the decision to make the commitment.

Call the Cancer Hot Line at 800-433-0464 to request a copy of Fighting Cancer and to ask for a list of institutions that provide a multidisciplinary second opinion..All of this and much more is yours for the asking.

There is a saying that it takes 6 things to beat cancer. First is the best possible medical treatment. Second is the best possible medical treatment. Third, fourth and fifth are the best medical treatment. Sixth is a positive mental attitude. Without all 6, you don't have a chance. But look at it in that perspective and relative importance. A positive mental attitude is not burying your head in the sand and saying' "I'm going to get well." It is doing everything within your power in addition to medicine to help yourself recover.

That "everything" is to thoroughly read and digest the book, "Fighting Cancer" that you received by calling 800-433-0464. It is written in plain English to help you understand your disease and do everything in your power to help you fight it. The last chapter is a check list.

Fighting cancer is not a simple matter of thinking positively, wishing it away and saying, "Hey, doc, cure me." It is a matter of knowledge. It is a matter of educating yourself about every detail and mustering all your resources. Use every drop of energy in an organized fashion to constructively concentrate on getting rid of cancer. Most cancers can be successfully treated, but generally you have only one chance. If you miss that first chance, if you don't do everything in your power, often there is no second chance.

This is why no cancer patient can afford the luxury of looking back and saying, "I wish I would have...." Never look back. Concentrate on this moment forward and do everything in your power. There is no downside risk. Now you may have a chance.

Good Luck & God Bless You,

Dick Bloch



If you, a coworker or a family member has been exposed to asbestos, contact the law firm of LEVY PHILLIPS & KONIGSBERG, LLP. LPK has been a pioneer in representing victims of asbestos exposure, and is one of the nation’s premier law firms in the areas of toxic torts, product liability, personal injury, and discrimination law.

Friday, February 01, 2008

$15.3 million award in meso lawsuit

According to an article on mesothelioma at baltimoresun.com, a man was paid a $15.3 million award in an asbestos-related lawsuit:

A Baltimore jury ordered a sealant company yesterday to pay a 73-year-old man $15.3 million after determining that he developed mesothelioma from exposure to asbestos-containing products made by the company, the plaintiff's lawyer said.



George J. Linkus worked at Key Highway Shipyard from 1952 to 1959, said his lawyer, David L. Palmer.



In 1954, Linkus moved to the machine shop and worked on lining valves using rope made by the defendant, John Crane Inc.



The jury found that the rope used by Linkus contained asbestos, Palmer said.
Mesothelioma is a cancer directly linked to asbestos. Yesterday's verdict concluded a three-week trial.


----


If you, a coworker or a family member has been exposed to asbestos, contact the law firm of LEVY PHILLIPS & KONIGSBERG, LLP. LPK has been a pioneer in representing victims of asbestos exposure, and is one of the nation’s premier law firms in the areas of toxic torts, product liability, personal injury, and discrimination law.

Thursday, January 24, 2008

First-Time Federal Funding for Mesothelioma Research

According to a recent press release on mesothelioma research, the Department of Defense (DoD) Peer Reviewed Medical Research Program was appropriated $50 million in the Defense Appropriations Bill that the President signed in mid-November.

The Mesothelioma Applied Research Foundation (Meso Foundation) is excited to announce that, for the first time, mesothelioma will be included as a research priority within the DoD's Medical Research Program, to begin February 2008. As a candidate research area within the program, mesothelioma investigators are eligible to compete for funding through the program's 2008 grant cycle.

"The Meso Foundation has been working with fifteen senators, led bySenator Max Baucus (D-MT), advocating the federal government to respond to the mesothelioma crisis through a commitment of new federal research dollars," said Chris Hahn, Executive Director of The Meso Foundation. "Our advocacy efforts in this area for the past several years finally paid off."

Federal medical research projects must be of clear scientific merit and have direct relevance to military health. Military relevance is a key feature of the Investigator-Initiated award, a connection that will not be difficult for mesothelioma researchers to establish for their grant applications.

There is a long history of asbestos exposure in military service, and a significant elevated risk of mesothelioma in the military population. In fact, approximately one third of mesothelioma cases have been shown to involve Navy and shipyard exposures. Given the long latency of the disease, even if exposures are reduced, mesothelioma will continue to affect the veteran and military population for decades to come.

This funding opportunity can serve as a vital resource to the mesocommunity and is another crucial step toward advancing the research andtreatment of mesothelioma. The Meso Foundation strongly encouragesmesothelioma investigators to consider submitting applications for fundingin 2008, as the interest and engagement shown by the community will likelybe a factor in whether mesothelioma is included as a candidate in future years.

Thursday, January 17, 2008

Par unit buys licensing rights for malignant mesothelioma drug

Par Pharmaceutical Companies Inc.'s (NYSE:PRX) proprietary products division said Tuesday it has acquired the exclusive licensing and commercialization rights to Onconase from Alfacell Corp. (NASDAQ:ACEL)



Onconase is a drug used in the treatment of inoperable malignant mesothelioma currently in Phase III development.



Under the terms of the agreement, Par's Strativa Pharmaceuticals unit will make an initial payment of $5 million to Alfacell. It will also pay an additional $30 million upon approval of the drug by the Food and Drug Administration.



Alfacell will retain the right to co-promote Onconase in the future and is also entitled to royalty payments from sales, as well as possible milestone payments of an undisclosed amount.



Alfacell is a Bloomfield, N.J.-based pharmaceutical company. Its stock closed Monday at $1.75.



Par is a Woodcliff Lake, N.J.-based pharmaceutical company. Its stock closed Monday at $20.97.

Thursday, January 03, 2008

Jury Awards $9 million to New York Mesothelioma Victims

On December 17, 2007, a New York City jury awarded a total of $9 million to compensate two New York City mesothelioma victims and their wives for damages caused by asbestos exposure. The two cases (Rosenberg and Casale) were joined for a single trial in New York County Supreme Court. The mesothelioma law firm representing both families is Levy Phillips & Konigsberg, LLP ("LPK") whom have represented New York families affected by mesothelioma for more than two decades.

The jury verdicts in these cases are being viewed as ground-breaking by mesothelioma trial attorneys, as the verdicts were handed down against companies against whom no jury verdicts had ever been returned in the long history of asbestos exposure litigation in New York City.

The case of Joel and Sharon Rosenberg v. Alpha Wire Company, et. al, Index No. 106697/06 involved the asbestos exposure that Mr. Rosenberg sustained as the result of working as a life-long electrician in New York with the International Brotherhood of Electrical Workers ("IBEW"), Local 3. The jury awarded $3 million for Mr. Rosenberg's pain and suffering and $1 million to Mrs. Rosenberg for loss of services and society. Mr. Rosenberg developed mesothelioma during his retirement while living in New Jersey. He died at the age of sixty-four.

The Casale case (Joseph and Dolores Casale, Index No. 104299/06), involved the asbestos exposure of Mr. Casale during his career as a steam fitter (also known as pipe fitter) in New York. The jury awarded a total of 5 million dollars in the Casale case: 1.5 million for Mr. Casale's pain and suffering up to the date of the verdict; 1.5 million for Mr. Casale's future pain and suffering; 1 million for Mrs. Casale's loss of service and society up to the date of the verdict; and 1 million for Mrs. Casale's future loss of service and society.

In the Casale case, the New York jury returned a verdict in favor of the Casales against a manufacturer of valves, as well as a manufacturer of steam traps. This represents the first verdicts involving valves and steam traps in the history of asbestos exposure litigation in New York, and is reportedly the first asbestos verdict in the nation involving the use of steam traps.

The LPK mesothelioma trial attorneys that obtained the verdicts in these cases were Jerome H. Block, Patrick J. Timmins and Holly C. Peterson. These mesothelioma trial attorneys at LPK (the attorneys for the Rosenberg and Casale families) have won numerous other landmark jury verdicts in the course of more than 25 years of representing New York mesothelioma victims.

For more information about this mesothelioma trial, LPK's mesothelioma trial attorneys, or for more information about mesothelioma and asbestos exposure, please call the mesothelioma attorneys at Levy, Phillips & Konigsberg LLP at 800-MESO-LAW or 212-605-6200, visit www.lpklaw.com or complete the email form on this page. You will also find informative medical and legal information about New York and New Jersey mesothelioma and asbestos exposure at www.nynjmesothelioma.com.

Mesothelioma Treatment Options

Mesothelioma Treatment Options

Here’s a very informative article on treatment options for malignant mesothelioma:

Treatment of malignant mesothelioma can be very difficult for a wide variety of reasons. First and foremost, mesothelioma can be difficult to correctly diagnose and may not show up in a patient for decades. This can create problems for treatment because with mesothelioma, as with all cancers, treatment is more difficult the longer the disease has been allowed to progress.

In addition to the difficulties created by delayed treatment of mesothelioma, the disease often does not respond to traditional cancer treatments, further complicating treatment. Also, the organs that are involved in mesothelioma cannot be partially or wholly removed usually, which means that surgical options can be extremely limited. Lastly, the fact that the majority of mesothelioma patients are men of advanced age, usually over 50, means that some more radical treatment approaches cannot be used because of declining health due to old age.

All of this means that even newly diagnosed mesothelioma patients sometimes are given a very bad chance of recovery by their doctors. Statistics are hard to come by, but British scientists suggest that 10% of newly diagnosed mesothelioma patients will live for at least three more years; Only 5% will live five years or longer. For patients in the first stage, 50% live for at least two more years. However doctors can be mistaken, and a diagnosis of mesothelioma is in no way always tantamount to a death sentence. Famed scientist Stephen Jay Gould lived with peritoneal mesothelioma for nearly 20 years. He eventually died from a different type of cancer.

There are four stages of malignant mesothelioma, which measure how far the disease has progressed. How a patient's mesothelioma is treated depends largely on which stage he or she is in when the disease is found.Patients with Stage I or milder Stage II mesothelioma are generally offered one or more of the conventional cancer treatments: surgery, radiation and chemotherapy.

Treatment Options:

Surgery
For early-stage patients, surgery for mesothelioma aims to cure the disease by literally cutting the cancer out of the patient's body. The most common type of surgery for pleural mesothelioma is a pleurectomy/decortication, which is where doctors remove all or part of the tissues lining the lungs and chest cavity.

Radiation and Chemotherapy
In addition to or instead of surgery, doctors may offer an early-stage mesothelioma patient chemotherapy, radiation or both. Radiation and chemotherapy are designed to kill the cancer cells without killing the patient.

Unfortunately, in order to kill the cancerous cells, these treatments often kill healthy cells as well. This is why cancer patients often lose their hair, have trouble eating and feel generally weak and sick during treatment. Doctors who prescribe chemotherapy or radiation may also suggest dietary supplements or other measures to control these symptoms.

Chemotherapy gives patients a drug designed to attack the cancer cells as they divide. The drug is swallowed or injected into the bloodstream regularly over a period of weeks or months, in cycles that give a patient some recovery time in between treatments. Patients can live at home and just go into a doctor's office for the treatment; sometimes, they can even have the treatments at home.

Radiation therapy seeks to kill the cancer cells with high-energy rays of radiation, such as x-rays, that stop them from growing. With external-beam radiation, patients will be subjected to directed rays of radiation directed as specific parts of the body affected by cancer. This treatment lasts about 30 minutes a day and is given in the exact same way each day over a period of weeks.

*****
If you, a coworker or a family member has been exposed to asbestos, contact the law firm of LEVY PHILLIPS & KONIGSBERG, LLP. LPK has been a pioneer in representing victims of asbestos exposure, and is one of the nation’s premier law firms in the areas of toxic torts, product liability, personal injury, and discrimination law.